REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilab Laboratorio Clinico Y Citologico Sas (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Unilab Laboratorio Clinico Y Citologico Sas Profile Updated: February 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Unilab Laboratorio Clinico Y Citologico Sas is based in Colombia. The head office is in La union. It operates in the Diagnostic Imaging Centers industry. The company was established on October 02, 2015. The company’s latest financial report indicates a net sales revenue increase of 36.06% in 2025. There was a total growth of 39.92% in Unilab Laboratorio Clinico Y Citologico Sas’s total assets over the same period. The net profit margin of Unilab Laboratorio Clinico Y Citologico Sas increased by 7.97% in 2025.

Headquarters
Cr 4 11 10 Brr San Antonio
La union; Narino;

Contact Details: Purchase the Unilab Laboratorio Clinico Y Citologico Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Unilab Laboratorio Clinico Y Citologico Sas report to view the information.
Financial Auditors:
Purchase the Unilab Laboratorio Clinico Y Citologico Sas report to view the information.
Incorporation Date:
October 02, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unilab Laboratorio Clinico Y Citologico Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
36.06%
Total Operating Revenue
36.06%
Operating Profit
47.97%
EBITDA
38.75%
Net Profit/Loss for the Period
199.01%
Total Assets
39.92%
Total Equity
48.47%
Operating Profit Margin
1.95%
Net Profit Margin
7.97%
Return on Equity (ROE)
16.44%
Debt / Equity
-8.6%
Quick Ratio
0.04%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?